332 636

Cited 10 times in

Cited 11 times in

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis

DC Field Value Language
dc.contributor.authorKwon, Oh Chan-
dc.contributor.authorPark, Jung Hwan-
dc.contributor.authorPark, Hyeong-Cheon-
dc.contributor.authorJung, Seung Min-
dc.contributor.authorLee, Sang-Won-
dc.contributor.authorSong, Jason Jungsik-
dc.contributor.authorPark, Yong-Beom-
dc.contributor.authorPark, Min-Chan-
dc.date.accessioned2020-09-28T12:02:43Z-
dc.date.available2020-09-28T12:02:43Z-
dc.date.created2021-03-18-
dc.date.issued2020-06-
dc.identifier.issn1478-6354-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/179324-
dc.description.abstractBackground To investigate non-histologic factors that can discriminate proliferative lupus nephritis (LN) from membranous LN in patients with systemic lupus erythematosus with renal manifestations. Methods Patients with biopsy-proven proliferative LN (class III +/- V and class IV +/- V) and membranous LN (class V) were included. Non-histologic factors were compared between the two groups. A logistic regression analysis was performed to identify the factors associated with proliferative LN. To assess the accuracy of these factors in discriminating between proliferative LN and membranous LN, we performed a receiver-operating characteristic analysis. Results Of the total 168 patients with biopsy-proven LN, 150 patients (89.3%) had proliferative LN, and 18 patients (10.7%) had membranous LN. In the multivariable logistic regression analysis, positive anti-double-stranded DNA (anti-dsDNA) antibody (adjusted OR = 11.200, 95% CI = 2.202-56.957,p = 0.004) was associated with proliferative LN, while positive anti-U1RNP antibody (adjusted OR = 0.176, 95% CI = 0.040-0.769,p = 0.021) and higher glomerular filtration rate (GFR) (adjusted OR = 0.973, 95% CI = 0.951-0.994,p = 0.013) were inversely associated with proliferative LN. Among these covariates, the anti-dsDNA antibody (area under the curve = 0.806, 95% CI = 0.695-0.916) had the highest accuracy in discriminating between proliferative LN and membranous LN. Conclusion The positivity of anti-dsDNA antibody was associated with proliferative LN, while the positivity of anti-U1RNP antibody and GFR were inversely associated with proliferative LN. The anti-dsDNA antibody had a good accuracy in discriminating proliferative LN from membranous LN.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherBioMed Central-
dc.relation.isPartOfARTHRITIS RESEARCH & THERAPY-
dc.relation.isPartOfARTHRITIS RESEARCH & THERAPY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleNon-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorKwon, Oh Chan-
dc.contributor.googleauthorPark, Jung Hwan-
dc.contributor.googleauthorPark, Hyeong-Cheon-
dc.contributor.googleauthorJung, Seung Min-
dc.contributor.googleauthorLee, Sang-Won-
dc.contributor.googleauthorSong, Jason Jungsik-
dc.contributor.googleauthorPark, Yong-Beom-
dc.contributor.googleauthorPark, Min-Chan-
dc.identifier.doi10.1186/s13075-020-02223-x-
dc.relation.journalcodeJ00241-
dc.identifier.eissn1478-6362-
dc.subject.keywordSystemic lupus erythematosus-
dc.subject.keywordLupus nephritis-
dc.subject.keywordProliferative-
dc.subject.keywordMembranous-
dc.contributor.alternativeNameSong, Jason Jungsik-
dc.contributor.affiliatedAuthorKwon, Oh Chan-
dc.contributor.affiliatedAuthorPark, Jung Hwan-
dc.contributor.affiliatedAuthorPark, Hyeong-Cheon-
dc.contributor.affiliatedAuthorJung, Seung Min-
dc.contributor.affiliatedAuthorLee, Sang-Won-
dc.contributor.affiliatedAuthorSong, Jason Jungsik-
dc.contributor.affiliatedAuthorPark, Yong-Beom-
dc.contributor.affiliatedAuthorPark, Min-Chan-
dc.identifier.scopusid2-s2.0-85086355088-
dc.identifier.wosid000541551300002-
dc.citation.volume22-
dc.citation.number1-
dc.identifier.bibliographicCitationARTHRITIS RESEARCH & THERAPY, Vol.22(1), 2020-06-
dc.identifier.rimsid69578-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorSystemic lupus erythematosus-
dc.subject.keywordAuthorLupus nephritis-
dc.subject.keywordAuthorProliferative-
dc.subject.keywordAuthorMembranous-
dc.subject.keywordPlusCLUSTER-ANALYSIS-
dc.subject.keywordPlusERYTHEMATOSUS-
dc.subject.keywordPlusMANAGEMENT-
dc.subject.keywordPlusDISEASE-
dc.subject.keywordPlusAUTOANTIBODIES-
dc.subject.keywordPlusCLASSIFICATION-
dc.subject.keywordPlusANTIBODIES-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryRheumatology-
dc.relation.journalResearchAreaRheumatology-
dc.identifier.articleno138-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.